Table of Contents

2019-2024 Global Neurological Biomarkers Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Neurological Biomarkers Consumption 2014-2024
  • 2.1.2 Neurological Biomarkers Consumption CAGR by Region
• 2.2 Neurological Biomarkers Segment by Type
  • 2.2.1 Proteomics
  • 2.2.2 Genomics
  • 2.2.3 Imaging
  • 2.2.4 Bioinformatics
  • 2.2.5 Others
• 2.3 Neurological Biomarkers Consumption by Type
  • 2.3.1 Global Neurological Biomarkers Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Neurological Biomarkers Sale Price by Type (2014-2019)
• 2.4 Neurological Biomarkers Segment by Application
  • 2.4.1 Diagnostics
  • 2.4.2 Drug Discovery
  • 2.4.3 Personalized Medicine
  • 2.4.4 Others
• 2.5 Neurological Biomarkers Consumption by Application
  • 2.5.1 Global Neurological Biomarkers Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Neurological Biomarkers Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Neurological Biomarkers Sale Price by Application (2014-2019)

3 Global Neurological Biomarkers by Players

• 3.1 Global Neurological Biomarkers Sales Market Share by Players
  • 3.1.1 Global Neurological Biomarkers Sales by Players (2017-2019)
  • 3.1.2 Global Neurological Biomarkers Sales Market Share by Players (2017-2019)
• 3.2 Global Neurological Biomarkers Revenue Market Share by Players
  • 3.2.1 Global Neurological Biomarkers Revenue by Players (2017-2019)
  • 3.2.2 Global Neurological Biomarkers Revenue Market Share by Players (2017-2019)
• 3.3 Global Neurological Biomarkers Sale Price by Players
• 3.4 Global Neurological Biomarkers Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Neurological Biomarkers Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Neurological Biomarkers Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Neurological Biomarkers by Regions

• 4.1 Neurological Biomarkers by Regions
  • 4.1.1 Global Neurological Biomarkers Consumption by Regions
  • 4.1.2 Global Neurological Biomarkers Value by Regions
• 4.2 Americas Neurological Biomarkers Consumption Growth
• 4.3 APAC Neurological Biomarkers Consumption Growth
• 4.4 Europe Neurological Biomarkers Consumption Growth
• 4.5 Middle East & Africa Neurological Biomarkers Consumption Growth

5 Americas

• 5.1 Americas Neurological Biomarkers Consumption by Countries
  • 5.1.1 Americas Neurological Biomarkers Consumption by Countries (2014-2019)
  • 5.1.2 Americas Neurological Biomarkers Value by Countries (2014-2019)
• 5.2 Americas Neurological Biomarkers Consumption by Type
• 5.3 Americas Neurological Biomarkers Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Neurological Biomarkers Consumption by Countries
  • 6.1.1 APAC Neurological Biomarkers Consumption by Countries (2014-2019)
  • 6.1.2 APAC Neurological Biomarkers Value by Countries (2014-2019)
• 6.2 APAC Neurological Biomarkers Consumption by Type
• 6.3 APAC Neurological Biomarkers Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Neurological Biomarkers by Countries
  • 7.1.1 Europe Neurological Biomarkers Consumption by Countries (2014-2019)
  • 7.1.2 Europe Neurological Biomarkers Value by Countries (2014-2019)
• 7.2 Europe Neurological Biomarkers Consumption by Type
• 7.3 Europe Neurological Biomarkers Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Neurological Biomarkers by Countries
  • 8.1.1 Middle East & Africa Neurological Biomarkers Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Neurological Biomarkers Value by Countries (2014-2019)
• 8.2 Middle East & Africa Neurological Biomarkers Consumption by Type
• 8.3 Middle East & Africa Neurological Biomarkers Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Neurological Biomarkers Distributors
• 10.3 Neurological Biomarkers Customer

11 Global Neurological Biomarkers Market Forecast

• 11.1 Global Neurological Biomarkers Consumption Forecast (2019-2024)
• 11.2 Global Neurological Biomarkers Forecast by Regions
  • 11.2.1 Global Neurological Biomarkers Forecast by Regions (2019-2024)
  • 11.2.2 Global Neurological Biomarkers Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Neurological Biomarkers Forecast by Type
• 11.8 Global Neurological Biomarkers Forecast by Application

12 Key Players Analysis

• 12.1 Thermo Fisher Scientific
  • 12.1.1 Company Details
  • 12.1.2 Neurological Biomarkers Product Offered
  • 12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Thermo Fisher Scientific News
• 12.2 Merck
  • 12.2.1 Company Details
  • 12.2.2 Neurological Biomarkers Product Offered
  • 12.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Merck News
• 12.3 Quest Diagnostics
  • 12.3.1 Company Details
  • 12.3.2 Neurological Biomarkers Product Offered
  • 12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Quest Diagnostics News
• 12.4 Abbott
  • 12.4.1 Company Details
  • 12.4.2 Neurological Biomarkers Product Offered
  • 12.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Abbott News
• 12.5 Roche
  • 12.5.1 Company Details
  • 12.5.2 Neurological Biomarkers Product Offered
  • 12.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Roche News
• 12.6 Illumina
  • 12.6.1 Company Details
  • 12.6.2 Neurological Biomarkers Product Offered
  • 12.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Illumina News
• 12.7 Bio-Rad Laboratories
  • 12.7.1 Company Details
  • 12.7.2 Neurological Biomarkers Product Offered
  • 12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Bio-Rad Laboratories News
• 12.8 QIAGEN
  • 12.8.1 Company Details
  • 12.8.2 Neurological Biomarkers Product Offered
  • 12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 QIAGEN News
• 12.9 Myriad RBM
  • 12.9.1 Company Details
  • 12.9.2 Neurological Biomarkers Product Offered
  • 12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Myriad RBM News
• 12.10 Cisbio Bioassays
  • 12.10.1 Company Details
  • 12.10.2 Neurological Biomarkers Product Offered
  • 12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Cisbio Bioassays News
• 12.11 Athena Diagnostics
• 12.12 BGI
• 12.13 Wuxi APP
• 12.14 Aepodia
• 12.15 Proteome Sciences
• 12.16 Genewiz

13 Research Findings and Conclusion

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.
Neurological Biomarkers is widely used in Diagnostics, Drug Discovery, Personalized Medicine and other field. The most proportion of Neurological Biomarkers is used for Diagnostics, and the revenue in 2017 is 1.35 billion USD.
North America is the largest consumption place, with a consumption market share nearly 57% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

According to this study, over the next five years the Neurological Biomarkers market will register a 9.4% CAGR in terms of revenue, the global market size will reach US$ 7380 million by 2024, from US$ 4710 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Neurological Biomarkers business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Biomarkers market by product type, application, key manufacturers and key regions and countries.

This study considers the Neurological Biomarkers value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Proteomics
Genomics
Imaging
Bioinformatics
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Diagnostics
Drug Discovery
Personalized Medicine
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Neurological Biomarkers consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Neurological Biomarkers market by identifying its various subsegments.
Focuses on the key global Neurological Biomarkers manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Neurological Biomarkers with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Neurological Biomarkers submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.